SUMMARY 107 patients with neonatal tetanus were studied and the value of intrathecal antitetanus serum with steroid was noted. The mortality rate in a control group (68%) was significantly higher than that ofthe test group (37%). Furthermore, a delay in antitetanus serum administration was found to have a strong positive linear correlation with the mortality rate. In fact, the mortality rate for neonates who were given antitetanus serum 24 hours after the onset of convulsions was found to be as high as for the control group. This suggests that intrathecal antitetanus serum is ineffective unless it is administered within 24 hours of the onset of convulsions. There was no significant difference in mortality rate whether a dose of 100 units or one of 50 units antitetanus serum was given intrathecally. The mean duration in hospital for survivals of the test group (7-4 days) was significantly shorter than that for survivals of the control group (10.4 days). No complication of intrathecal antitetanus serum was observed during the study.
Neonatal tetanus is associated with a high mortality and accounts for about 55 % of neonatal deaths in rural India.' In one survey2 it was reported to be the second most common killer of neonates; the first was prematurity. In many places the mortality even today ranges from 70 to 90% (Table 1) . We have tried to reduce this mortality rate by using a method of treatment which is both economical and feasible, even for centres lacking elaborate facilities.
Experimental studies with intrathecal antitetanus serum (ATS) in animals have shown encouraging results.35 17 Some workers 6-8 have tried ATS in adults with tetanus, but little work has been done to assess its value in the treatment of tetanus neonatorum.9 Care of umbilical stump. The umbilical cord of each patient was cleaned daily with spirit and 1 % Patients with all five features were classified as having grade V severity, those with four were grade IV, those with only three were grade III, and so on. The majority of cases were grade IV or V. There were only 2 patients with grade II; both were in the control group and both survived. No case of grade I tetanus was brought to the hospital. The degree of severity was similar in both groups.
Severity of the disease was clearly related to mortality (Table 5) .
11 patients with grade II or III severity were given schedule I sedation. 66 patients with grade IV or V severity were given schedule 2, while 22 patients (12 in the test group and 10 in the control group) were given parenteral sedation (schedule 3). 17 patients given schedule 3 died (9 in the test group and 8 in the control group).
Delay in giving intrathecal ATS. A linear relation exists between the delay in giving intrathecal ATS and mortality (Table 6 ). There is also a steep rise in mortality if ATS is given later than 24 hours after onset, although the number of cases in this group was small. This suggests that delay in giving ATS intrathecally is associated with higher rates of mortality, and that ATS is not of much benefit if group.bmj.com on October 14, 2017 -Published by http://adc.bmj.com/ Downloaded from given later than 24 hours after the onset of the first spasm (Table 6 ).
Dose of intrathecal ATS. ATS intrathecally was given with 2 mg of dexamethasone in two subgroups. 100 units of ATS were given to 26 patients (subgroup A) and 50 units ATS to 23 patients (subgroup B). 9 patients died in each subgroup. Case fatality rates were 35 and 39% respectively for subgroups A and B. These data show there was no appreciable difference (X2 = 0 105; df = 1) in fatality rates whether a dose of 100 units or 50 units ATS was given.
Hospital stay. Intrathecal ATS helped to reduce the duration spent in hospital (Table 7) . Generally the hospital stay for patients in the test group was 7X4 days while that for patients in the control group was 10 4 days; the difference is significant (P<0.05).
Time of death. 
Discussion
Tetanus antiserum with dexamethasone administered directly into the cerebrospinal fluid has reduced the mortality in tetanus neonatorum and hastened recovery from the infection (Tables 2 and 7) . ATS given within 24 hours from the onset of convulsions was effective, but if given later the results were less convincing ( In summary, we believe that the administration of intrathecal ATS with steroid is effective. Our patients in both groups had tetanus of a similar degree of severity (Table 5) , they were given the same schedules of treatment, and had the same nursing care. Previous results for tetanus neonatorum12 from the same institution gave a mortality rate of 79 %. 
